Content matching 'embryonic stem cells'
Part 1 from the conference scene of the World Stem Cell Summit (WSCS) 2014 held in San Antonio (3–5 December, San Antonio, Texas)
The need for developments within the regenerative medicine field is illustrated by the number of funding opportunities in the H2020 2016-2017 work programme. A common denominator for all of these calls is the presence of in-human data. They provide a highly competitive edge, as only a limited amount of companies and/or research groups were able to perform first in-human experiments to date.
The technological developments that have allowed organoids to become a viable research tool and the remaining challenges in their production
The Regulation of Clinical Stem Cell Research and Applications: three dynamics of global regulatory diversification (part 2)
The commercialization of cell and gene therapies: regulatory challenges